Der er millioner på vej til en ny life science-strategi, efter et bredt flertal i Folketinget onsdag er blevet enige om en større stimuli-pakke.
Konturerne til den life science strategi, som den danske life science-sektor længe har tørstet efter, tegner sig nu i horisonten.
Onsdag er et bredt flertal i Folketinget blevet enige om en større stimuli-pakke til dansk økonomi, der blandt andet indeholder en eksportpakke på 575 mio. kr. årligt frem til 2023 – og herunder 70 mio. kr. om året til en ny life science strategi.
Allerede abonnent? Log Ind.
Associate Director Medical Science – Orphazyme 
Medicochef til medicoteknologi i største skala - Region Hovedstaden 
Senior Cost Accountant - Zealand Pharma 
BRIDGE – Translational Excellence Programme: Call for Outstanding Postdocs and Experienced Mentors interested in Translational Medicine 
Scientist Cell Culture - Tech Transfer, Fujifilm Diosynth Biotechnologies Senior Scientist, Analytical Development - Zealand Pharma 
Senior Accountant - Y-mAbs Therapeutics Manager of Medical Writing - Orphazyme 
Artwork Coordinator - Orifarm 
Nordic General Director, Pharma - MEDICE Associate Director, GMP QA, Commercial Operations - Y-mAbs Therapeutics 
Director CMC, Drug Product - Galecto Director of Clinical Quality Assurance Operations – Orphazyme QC specialist søges - Orifarm Senior Clinical Trial Manager - Zealand Pharma 
Senior Programming Manager - Genmab Senior Medical Writer - Orphazyme Director CMC, Drug Substance - Galecto Supply Chain Manager - Y-mAbs Therapeutics Senior CMC Specialist, Analytical - Genmab Pharmacovigilance Specialist - Orifarm 
Experienced Clinical Project Manager - ALK 
Experienced Scientist - LEO Pharma 
QC Manager Drug Substance for Product Supply – Ascendis Pharma QAA Team Manager - Orifarm 
Sundhedsfaglig chef - Sano 
Erfaren jurist med interesse for lægemiddelområdet - Amgros Director Pharmacology & New Target Discovery - Y-mAbs 
CMC Project Manager – MC2 Therapeutics 
Er du konsulent med ingeniørbaggrund? - Andreasen & Elmgaard Senior Manager, Internal Communications - Genmab Senior Principal IT Business Partner - Genmab 
Merck – Director Market Access 
Senior Manager Business Development - Ascelia Pharma Regulatory Affairs Manager – MC2 Therapeutics 
